IMAC HOLDINGS INC (IMAC) Stock Overview
USA - NASDAQ:IMAC - US44967K1043 - Common Stock
IMAC Key Statistics, Chart & Performance
The current stock price of IMAC is 1.01 USD. In the past month the price increased by 2.54%. In the past year, price decreased by -35.67%.
IMAC Latest News, Press Relases and Analysis
IMAC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 17.28 | 104.60B | ||
| THC | TENET HEALTHCARE CORP | 14.26 | 18.59B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 11.19 | 13.41B | ||
| EHC | ENCOMPASS HEALTH CORP | 25.38 | 12.70B | ||
| ENSG | ENSIGN GROUP INC/THE | 31.06 | 10.74B | ||
| SGRY | SURGERY PARTNERS INC | 27.14 | 2.92B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 17 | 2.68B | ||
| ARDT | ARDENT HEALTH INC | 8.5 | 2.18B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 8.41 | 2.16B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.10B | ||
| PACS | PACS GROUP INC | 16.66 | 1.96B | ||
| NHC | NATIONAL HEALTHCARE CORP | 18.29 | 1.90B |
Related stock screener links
About IMAC
Company Profile
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Brentwood, Tennessee and currently employs 154 full-time employees. The company went IPO on 2019-02-13. The firm provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, non-invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. Its BACKSPACE retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. The firm is also conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. The firm operates approximately 17 outpatient medical clinics in six states and four BackSpace locations in two states of United States.
Company Info
IMAC HOLDINGS INC
1605 Westgate Cir
Brentwood TENNESSEE 37027 US
CEO: Jeffrey S. Ervin
Employees: 154
Phone: 18442664622.0
IMAC HOLDINGS INC / IMAC FAQ
What does IMAC HOLDINGS INC do?
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Brentwood, Tennessee and currently employs 154 full-time employees. The company went IPO on 2019-02-13. The firm provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, non-invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. Its BACKSPACE retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. The firm is also conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. The firm operates approximately 17 outpatient medical clinics in six states and four BackSpace locations in two states of United States.
What is the stock price of IMAC HOLDINGS INC today?
The current stock price of IMAC is 1.01 USD. The price increased by 2% in the last trading session.
Does IMAC stock pay dividends?
IMAC does not pay a dividend.
What is the ChartMill rating of IMAC HOLDINGS INC stock?
IMAC has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is IMAC HOLDINGS INC (IMAC) stock traded?
IMAC stock is listed on the Nasdaq exchange.
Can you provide the market cap for IMAC HOLDINGS INC?
IMAC HOLDINGS INC (IMAC) has a market capitalization of 26.75M USD. This makes IMAC a Nano Cap stock.
IMAC Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to IMAC. When comparing the yearly performance of all stocks, IMAC turns out to be only a medium performer in the overall market: it outperformed 43.31% of all stocks.
IMAC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IMAC. Both the profitability and financial health of IMAC have multiple concerns.
IMAC Financial Highlights
Over the last trailing twelve months IMAC reported a non-GAAP Earnings per Share(EPS) of -0.38. The EPS increased by 13.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -76.98% | ||
| ROA | -48.41% | ||
| ROE | N/A | ||
| Debt/Equity | 0.01 |
IMAC Forecast & Estimates
8 analysts have analysed IMAC and the average price target is 3.59 USD. This implies a price increase of 255.15% is expected in the next year compared to the current price of 1.01.
For the next year, analysts expect an EPS growth of 2.98% and a revenue growth 21.45% for IMAC